Why Is Karyopharm Therapeutics ( $KPTI ) Stock Down -7.38% Today? (Find out why any stock moved today on Tickeron.) KPTI shares fell about 7.38% to $1.13 in Thursday's session, down from a prior close of $1.22. The decline extends a prolonged slide driven by acute financial distress and a looming forbearance deadline. Karyopharm is operating under a Forbearance Agreement with lenders after missing debt payments, with liquidity concerns front and center. $MBRX $GLUE $ARRY $DMRA
published
Why Is Karyopharm Therapeutics ( $KPTI ) Stock Down -7.38% Today? (Find out why any stock moved today on Tickeron.) KPTI shares fell about 7.38% to $1.13 in Thursday's session, down from a prior close of $1.22. The decline extends a prolonged slide driven by a
$KPTI$MBRX$GLUE$ARRY$DMRA
Latest documented BWB result
$APP market result
Sold the $280 10/9 Calls on $APP for $7.80
Historical results are not a promise of future performance. Trading involves substantial risk.This public post is a timestamped information archive, not personalized financial advice. Alerts can change as markets move. Join Billy's private group for the complete daily stream and follow-through.